Presentation TCT 2016 Procedural Anticoagulants: Limitations, Use Recommendations and, Investigational Agents Presenter: Harvey D. White October 30, 2016 REGISTER for free or LOG IN to view this content Clinical Cardiology Presentation TCT 2016 Clinical Pharma Up Next Presentation TCT 2016 Chronic Oral Anticoagulants: Limitations, Use Recommendations, and Investigational Agents Presenter: Christopher B. Granger October 30, 2016 More slides + Presentation TCT 2016 Heart Failure Advances (Ivabradine, ARNI, and More) Presenter: Clyde W. Yancy October 30, 2016 Presentation TCT 2016 Personalized Medicine Where Are We in 2016? Presenter: Clyde W. Yancy October 30, 2016 We Recommend
Presentation TCT 2016 Chronic Oral Anticoagulants: Limitations, Use Recommendations, and Investigational Agents Presenter: Christopher B. Granger October 30, 2016
Presentation TCT 2016 Heart Failure Advances (Ivabradine, ARNI, and More) Presenter: Clyde W. Yancy October 30, 2016
Presentation TCT 2016 Personalized Medicine Where Are We in 2016? Presenter: Clyde W. Yancy October 30, 2016